Sentinel Insight
- State
- MONITORING
- Impact
- MEDIUM
- Metric
- Psilocybin drug development advances
Psychedelic Alpha
Compass Closes Out Phase 3 With 6-Month COMP006 Data, Eyes H1’27 Launch
Analysis News Pα+ Analysis Compass Closes Out Phase 3 With 6-Month COMP006 Data, Eyes H1’27 Launch 7 July 2026 In this Article Efficacy Safety This morning, Compass Pathways shared 26-week data from its second Phase 3 study of COMP360 psilocybin
Get email alerts when mushroom laws change in your area.
Email AlertsMerchants: Add legal status to your store →
Verified vendor: MIT45 — 10% off with code
Shop official siteMUSHROOMBANSAffiliate relationships do not influence legislative reporting.